Papers

2

Total Citations

12

H-Index

2

About

Dr. Bo Liao is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for benign prostatic hyperplasia (BPH) and adrenal pathologies. His most impactful contribution is a comprehensive systematic review and meta-analysis comparing holmium laser enucleation of the prostate (HoLEP) versus robotic-assisted simple prostatectomy (RASP) for BPH, which has already garnered 7 citations since its 2025 publication. This work provides crucial evidence guiding surgical decision-making for large prostate glands. Dr. Liao has also made significant strides in adrenal surgery, authoring a pooled analysis comparing robotic posterior retroperitoneal adrenalectomy (RPRA) with the laparoscopic approach (LPRA), cited 5 times. This meta-analysis helps clarify the safety and efficacy profiles of these advanced techniques. Through these rigorous comparative effectiveness studies, Dr. Liao is shaping best practices in urologic surgery, offering surgeons and patients clearer data on outcomes. His research is essential reading for anyone interested in the evolution of robotic and laser-assisted urologic procedures.

Research Focus

Key Achievements

2
H-Index
2
Papers
12
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Comparative outcomes of holmium laser enucleation of the prostate (HoLEP) versus robotic-assisted simple prostatectomy (RASP) for benign prostatic hyperplasia: a systematic review and meta-analysis
7 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Affiliated Hospital of North Sichuan Medical College

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago